Meeting unmet medical needs has its price. Consider the 21st Century Cures legislation. The sweeping Congressional bill, which is designed to jumpstart medical innovation, has a provision that would allow the FDA to grant an extra six months of exclusive marketing rights to a company if an existing drug is approved to treat a rare disease. Jerry Avorn, professor of medicine at Brigham and Women’s Hospital, is quoted.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?